M.v.i. and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take M.v.i. (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Lantus (insulin glargine recombinant). Common drug interactions include colon cancer among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take M.v.i. and Lantus. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is M.v.i.?

M.v.i. has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. eHealthMe is studying from 2,498 M.v.i. users. Check the latest studies of M.v.i..

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 06, 2026

25 people who take M.v.i. and Lantus together, and have interactions are studied.

What are the common drug interactions of M.V.I. and Lantus, by gender? *:

female:

Colon cancer
Decreased appetite
Depressed level of consciousness
Diabetes mellitus inadequate control
Dyspnoea (difficult or laboured respiration)
Fall
Head injury
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Hyperkalaemia (damage to or disease of the kidney)

male:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection
Weight decreased
Weight increased
White blood cell count decreased
Abdominal discomfort
Abdominal distension
Abdominal pain upper

What are the common drug interactions of M.V.I. and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Renal atrophy (wasting of kidney)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Sepsis (a severe blood infection that can lead to organ failure and death)
Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
Social problem
Staphylococcal bacteraemia (a bacterial infection of blood)
Suicidal ideation
Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection

60+:

Weight decreased
Blood glucose decreased
Wheezing (a high-pitched whistling sound made while you breath)
Abdominal discomfort
Abdominal distension
Anaphylactic reaction (serious allergic reaction)
Bacterial infection
Chills (felling of cold)
Clostridial infection (infectious conditions by clostridium bacteria)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

What are the existing conditions these people have? *

Type 1 Diabetes: 3 people, 12.00%
High Blood Pressure: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take M.v.i. and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously